FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a stabilized pharmaceutical composition for thyroid hormone replacement therapy comprising 3,5-diiodo-O-[3-iodo-4-(sulfooxy)phenyl]-L-tyrosine (T3S) as an active substance in a micronized form.
EFFECT: pharmaceutical composition containing an active ingredient in a micronized form having better solubility and stability is obtained.
3 cl, 2 dwg, 6 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING SULPHATED DERIVATIVE OF 3,5-DIIODO-O-[3-IODOPHENYL]-L-TYROSINE | 2018 |
|
RU2708244C1 |
METHOD OF PRODUCING SULPHATED DERIVATIVE OF 3,5-DIIODO-O-[3-IODOPHENYL]-L-TYROSINE | 2012 |
|
RU2610093C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
BETA-LACTAMASE INHIBITORS | 2009 |
|
RU2445314C9 |
USE OF TRI-SUBSTITUTED BENZOPYRANONES | 2005 |
|
RU2383537C2 |
POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS OF PHARMACEUTICAL COMPOUND | 2010 |
|
RU2575173C2 |
PROCESS FOR PREPARATION OF LEVOTHYROXINE AND SALTS THEREOF | 2015 |
|
RU2673540C2 |
METHODS FOR MEASURING ELECTRIC CHEMICAL LUMINESCENCE AND DETECTION OF CONTENT OF MATERIAL, REACTANCE AGENT | 1994 |
|
RU2116647C1 |
POLYMORPHOUS AND PSEUDOPOLYMORPHOUS FORMS OF THE PHARMACEUTICAL COMPOUND | 2010 |
|
RU2727509C2 |
1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
Authors
Dates
2018-07-31—Published
2012-04-05—Filed